Evidence map›Paper›PMID 39080209›Full record

ArticlePhysical and engineering sciences in medicine2024

Dosiomics-based detection of dose distribution variations in helical tomotherapy for prostate cancer patients: influence of treatment plan parameters.

Marziyeh Mirzaeiyan, Ali Akhavan, Simin Hemati, Mahnaz Etehadtavakol, Alireza Amouheidari, Atoosa Adibi, Hossein Khanahmad, Zahra Sharifonnasabi, Parvaneh Shokrani

Abstract read
PubMed Publisher
In one paragraph

Article in Physical and engineering sciences in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marziyeh MirzaeiyanDepartment of Medical Physics, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID http://orcid.org/0000-0001-8876-0087
Ali AkhavanDepartment of Radiotherapy Oncology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Simin HematiDepartment of Radiotherapy Oncology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mahnaz EtehadtavakolDepartment of Medical Physics, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Alireza AmouheidariIsfahan Milad Hospital, Isfahan, Iran.
Atoosa AdibiDepartment of Radiology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Hossein KhanahmadDepartment of Genetics and Molecular Biology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Zahra SharifonnasabiDepartment of Statistics, University of Isfahan, Isfahan, Iran.
Parvaneh ShokraniDepartment of Medical Physics, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Shokrani@med.mui.ac.ir.ORCID http://orcid.org/0000-0002-9023-1923

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The stability of dosiomics features (DFs) and dose-volume histogram (DVH) parameters for detecting disparities in helical tomotherapy planned dose distributions was assessed. Treatment plans of 18 prostate patients were recalculated using the followings: field width (WF) (2.5 vs. 5), pitch factor (PF) (0.433 vs. 0.444), and modulation factor (MF) (2.5 vs. 3). From each of the eight plans per patient, ninety-three original and 744 wavelet-based DFs were extracted, using 3D-Slicer software, across six regions including: target volume (PTV), pelvic lymph nodes (PTV-LN), PTV + PTV-LN (PTV-All), one cm rind around PTV-All (PTV-Ring), rectum, and bladder. For the resulting DFs and DVH parameters, the coefficient of variation (CV) was calculated, and using hierarchical clustering, the features were classified into low/high variability. The significance of parameters on instability was analyzed by a three-way analysis of variance. All DF's were stable in PTV, PTV-LN, and PTV-Ring (average CV (

Indexed as

Prostatic NeoplasmsRadiotherapy DosageRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedDose-Response Relationship, RadiationHumansMaleRadiometryDosiomicsField widthHelical tomotherapyModulation factorPitchProstate cancerRadiotherapy

Identifiers

PMID39080209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.